TP53 alterations and patterns of carcinogen exposure in a U.S. population‐based study of bladder cancer
Open Access
- 14 September 2005
- journal article
- carcinogenesis
- Published by Wiley in International Journal of Cancer
- Vol. 117 (3) , 370-375
Abstract
The molecular pathology of bladder cancer has been the subject of considerable interest, and current efforts are targeted toward elucidating the interrelationships between individual somatic gene loss and both etiologic and prognostic factors. Mutation of theTP53gene has been associated with more invasive bladder cancer, and evidence suggests thatTP53mutation, independent of stage, may be predictive of outcome in this disease. However, there is no consensus in the literature that bladder carcinogen exposure is associated with inactivation of theTP53gene. Work to date has been primarily hospital based and, as such, subject to possible bias associated with selection of more advanced cases for study. We examined exposure relationships with bothTP53gene mutation and TP53 protein alterations in a population‐based study of 330 bladder cancer cases in New Hampshire. Tobacco smoking was not associated with TP53 alterations. We found a higher prevalence ofTP53inactivation (i.e.,mutation and nuclear accumulation) among hair dye users (odd ratio [OR] = 4.1; 95% confidence interval [CI] 1.2–14.7), and the majority of these mutations were transversions. Men who had “at risk” occupations were more likely to have mutatedTP53tumors (OR = 2.9; 95% CI 1.1–7.6). There also was a relative absence ofTP53mutation (OR = 0.4; 95% CI 0.0–2.9) and TP53 protein alterations (OR = 0.6; 95% CI 0.3–1.4) in bladder cancers from individuals with higher arsenic exposure. Our data suggest that there is exposure‐specific heterogeneity in inactivation of the TP53 pathway in bladder cancers and that integration of the spectrum of pathway alterations in population‐based approaches (capturing the full range of exposures to bladder carcinogens) may provide important insights into bladder tumorigenesis.Keywords
This publication has 33 references indexed in Scilit:
- Cancer Statistics, 2004CA: A Cancer Journal for Clinicians, 2004
- Expectant Management of Small, Recurrent, Noninvasive Papillary Bladder TumorsJournal of Urology, 2003
- P53 alterations in bladder tumors from arsenic and tobacco exposed patientsCarcinogenesis, 2003
- A Population-based Study of 538 Patients with Newly Detected Urinary Bladder Neoplasms Followed during 5 YearsScandinavian Journal of Urology and Nephrology, 2003
- The p53 Tumor Suppressor Gene and Nuclear Protein: Basic Science Review and Relevance in the Management of Bladder CancerJournal of Urology, 2003
- Permanent hair dyes and bladder cancer: risk modification by cytochrome P4501A2 and N-acetyltransferases 1 and 2Carcinogenesis, 2003
- p53 mutations in urinary bladder cancerBritish Journal of Cancer, 2001
- P53 point mutations in initial superficial bladder cancer occur only in tumors from current or recent cigarette smokers.Carcinogenesis, 2000
- Fluid Intake and the Risk of Bladder Cancer in MenNew England Journal of Medicine, 1999
- Identification of p53 Gene Mutations in Bladder Cancers and Urine SamplesScience, 1991